ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00263679
Brief Title: Assessment of GSK Biologicals' Tdap Candidate Vaccine Administered as a Booster (6th Dose) in Terms of Immunogenicity and Safety to Children and Adolescents Previously Vaccinated With Five Doses of an Acellular Pertussis-containing Vaccine.

First Submitted : December 8, 2005
First Submitted that Met QC Criteria : December 8, 2005
First Posted : December 9, 2005 (Estimate)

Last Update Submitted that Met QC Criteria : September 14, 2016
Last Update Posted : September 15, 2016 (Estimate)